Paper19642
Pathogenesis of vascular injury in rejecting rat renal allografts.
Anderson ND and 2 others. Johns Hopkins Med J, 1977. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Pathogenesis of vascular injury in rejecting rat renal allografts. Papers, record 19642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft Rejection | Major topic |
| Kidney Cortex Necrosis | Major topic |
| Kidney Transplantation | Major topic |
| Postoperative Complications | Major topic |
| Animals | |
| Complement C3 | |
| Drainage | |
| Endothelium | |
| Fluorescent Antibody Technique | |
| Graft Survival | |
| Graft vs Host Reaction | |
| Immunity | |
| Ischemia | |
| Isoantibodies | |
| Kidney Cortex | |
| Lymphocyte Depletion | |
| Rats | |
| Rats, Inbred BN | |
| Rats, Inbred Lew | |
| T-Lymphocytes | |
| Thoracic Duct | |
| Thymectomy | |
| Transplantation, Homologous |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6342410 | A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction. | Am J Pathol | 1983 | https://conductscience.org/library/papers/6342410 | PubMed |
| 3973015 | Structural and functional evolution of jejunal allograft rejection in rats and the ameliorating effects of cyclosporine therapy. | J Clin Invest | 1985 | https://conductscience.org/library/papers/3973015 | PubMed |
| 2713894 | Phenotypic heterogeneity of vascular endothelial cells in the human kidney. | Cell Tissue Res | 1989 | https://conductscience.org/library/papers/2713894 | PubMed |
| 379265 | Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. | J Exp Med | 1979 | https://conductscience.org/library/papers/379265 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19642
GET https://conductscience.org/api/papers/v1/19642/authors